Project Lazarus A community-wide response to managing pain.

Slides:



Advertisements
Similar presentations
National Prevention Strategy
Advertisements

THE COMMONWEALTH FUND 1 Comparing Health Care Systems Performance: Opportunities for Learning from Abroad Alliance for Health Reform April 11, 2008 Robin.
TRI science addiction Lost Opportunity? SBI for Substance Abuse In ERs and Trauma Centers Academy Health Mady Chalk, Ph.D. Treatment Research Institute.
Community Care of North Carolina The Honorable Verla Insko N.C. House of Representatives.
Update on Recent Health Reform Activities in Minnesota.
Life After HPRP Barbara Poppe, Executive Director, USICH March 26, 2012.
10/20/ The Pharmaceutical Industry and Their Influence on Pain Management in the ED J. David Haddox, DDS, MD VP, Risk Management & Health Policy.
T HE R OAD A HEAD LAC-DPH Strategic Plan Wendy K. Schiffer, MSPH Director of Planning, Evaluation, & Development County of Los Angeles Department of Public.
©2012 MFMER | slide-1 Family History Information Helps Inform Chronic Pain Treatment Elizabeth Pestka, MS, PMHCNS-BC, APNG Cynthia Townsend, PhD, LP Emily.
2014 National Patient Safety Goals
Opioid-Related Deaths and Mortality Rates by County, Wisconsin Residents Office of Health Informatics and AIDS/HIV and Hepatitis C Program Bureau.
Unintentional Drug Poisoning Deaths, Michigan Residents, Su Min Oh, PhD Michigan Department of Community Health Bureau of Substance Abuse and.
The Washington State Pharmacist Perspective
Provider Portal and IC Reports Update for Artemis Users May 20, 2014.
Mady Chalk, PhD., MSW Treatment Research Institute November, 2013.
Asthma in Minnesota Slide Set Asthma Program Minnesota Department of Health January 2013.
The Rubric Reality Cobb Keys Classroom Teacher Evaluation System.
Poison Prevention: A Prescription for a Safer and Healthier Georgia Megan Popielarczyk, MPH, BSN, RN Public Health Fellow, Safe Kids Georgia 1.
Prescription Drug Overdose National Perspective
Institute for Public Health, Medical Decision Making and Health Technology Assessment 1 Results of the PanEuropean Hepatitis C Project 3 rd Paris Hepatitis.
Project Lazarus/CCNC A statewide initiative to prevent drug overdose Dr. Robin Gary Cummings Deputy Secretary for Health Services State Health Director.
Use of a Universal Medication List to Enhance Continuity of Care in Tennessee.
Medical Director Jackson County Health and Human Services
Prescription Opioid Use and Opioid-Related Overdose Death — TN, 2009–2010 Jane A.G. Baumblatt, MD Centers for Disease Control and Prevention Epidemic Intelligence.
Prescription Drug Abuse Sharon Hertz, M.D. Medical Officer Division of Anesthetic, Critical Care and Addiction Drug Products Food and Drug Administration.
Development of a Road Map to Controlled Substance Diversion Prevention Rene Cronquist, RN, J.D. Director of Practice and Policy Minnesota Board of Nursing.
FUNDING OPPORTUNITIES. BACKGROUND New category of funding in the FY13 Harold Rogers Prescription Drug Monitoring Program Official title is “Category 3:
Chronic Pain Initiative CCNC and Project Lazarus: Chronic Pain and Community Initiative.
Overview Community Care of North Carolina. Our Vision and Key Principles  Develop a better healthcare system for NC starting with public payers  Strong.
A Safer Approach to Chronic Pain Management Tom Wroth MD, MPH Jerry McKee Pharm.D., M.S., BCPP NCCHCA Annual Conference Asheville, NC June 23, 2012.
Naloxone (Narcan) A true opioid overdose antidote.
The Opiate Crisis in Rural America Carol A. Cunningham, M.D., FAAEM, FACEP State Medical Director Ohio Department of Public Safety, Division of EMS Associate.
Preventing opioid poisonings Promoting responsible pain management.
Rx for Success Next Steps to Prevent Prescription Drug Abuse Rebecca Hebner, MPH Substance Abuse Prevention Systems Coordinator.
Improving Employee Safety at Spartanburg Regional Denise Hollis, RN, COHPM Mike Arntz, CHSP.
What are we doing in Southern Oregon? Concerns about opioid prescribing practices.
Asthma Disparities – A Focused Examination of Race and Ethnicity on the Health of Massachusetts Residents Jean Zotter, JD Director, Asthma Prevention and.
1 Alcohol and Substance Abuse Council of Jefferson County, Inc. 167 Polk Street, Suite 320 Watertown, New York Voice: ; Fax: ;
The Center for Health Systems Transformation
Rx Abuse in Workers’ Compensation
Origin and Process of Utah Guidelines Anna Fondario, MPH Utah Department of Health Violence and Injury Prevention Program.
Using drug use evaluation (DUE) to optimise analgesic prescribing in emergency departments (EDs) Karen Kaye, Susie Welch. NSW Therapeutic Advisory Group*
Welcome to the Safe Table. Carol Wagner, Senior Vice President Patient Safety Washington State Hospital Association Susan Callahan, Director of Community.
1 Prescribing Pain Medication – Guidelines for the Emergency Department April 22, 2012 Jennifer Sabel, PhD.
Summary Report and Recommendations on Prescription Drugs: Misuse, Abuse and Dependency Presentation for the County Alcohol and Drug Program Administrators’
Lesson 4Page 1 of 27 Lesson 4 Sources of Routinely Collected Data for Surveillance.
Reducing the Risk of Opioid Poisoning: Evaluation of a Community Based Approach Doug Easterling ( Jessica.
One Care of SWVA A Consortium of Substance Abuse Coalitions Sarah T. Melton, PharmD,BCACP,BCPP, FASCP Chair, One Care
North Carolina Community Care Networks (N3CN): Medical Home Access and Emergency Department (ED) Utilization May 2016.
Denis G. Patterson, DO ECHO Project April 20, 2016 CDC Guidelines for Prescribing Opioids for Chronic Pain.
A Community Mobilized to Take Action Marin County, California Kristen M Law, MA.
THE MANY FACES OF THE OPIOD EPIDEMIC
Wireless Access SSID: cwag2017
Opioid Prescribing CAPT Thomas Weiser, MD, MPH Medical Epidemiologist
New NC Medical Board Opioid Prescribing CME Requirements
Nebraska Prescription Drug Overdose Prevention Program Efforts
Caldwell County Narcotic Initiative
COLLECTIVE IMPACT APPROACH TO ADDRESSING
Project Lazarus A community-wide response to managing pain
Introduction to Clinical Pharmacy
ROOM project Addressing the Opioid Epidemic in the U.P.
Opioid Prescribing & Monitoring
Primary Prevention in the Time of the Opioid Epidemic
Opioids in Butte County
2019 Medicare Part D Rule Opioid-related Provisions
Chronic Pain Initiative
Impact of Policy and Regulatory Responses to the Opioid Epidemic on the Care of People with Serious Illness Hemi Tewarson, Director, Health Division National.
collaboration giving community 2018 HOUSTON OPIOID SUMMIT
Town of Collingwood Council September 10th, 2018 Mia Brown RN BScN
Community-Based Strategies for Preventing Opioid Abuse
Presentation transcript:

Project Lazarus A community-wide response to managing pain

2 Community Care of North Carolina (CCNC), in conjunction with non-profit organization Project Lazarus, is responding to some of the highest drug overdose death rates in the country through its Chronic Pain Initiative (CPI). Goals  Reduce opioid-related overdoses  Optimize treatment of chronic pain  Manage substance abuse issues (opioids)

3  A set of interrelated programs designed to improve the medical care received by chronic pain patients, and in the process, to reduce the misuse, abuse, potential for diversion and overdose from opioid medication. Key program components: ClinicalCommunity Focus Primary Care Physician ToolkitTake only your own medications Emergency Department ToolkitKeep medications in a safe place Care Management ToolkitEducation on dangers of opioids Network CPI Champion What is the Chronic Pain Initiative? Model is based on proper assessment, diagnosis, and treatment plan with Pain agreement as necessary

4 Why are we looking at replication? Evidence exists that the Wilkes County approach is changing conditions in ways that will reduce misuse, abuse, diversion and overdose from prescription opioids.  Changes in how medical professionals manage chronic pain patients and monitor their prescription use.  Change in opioid prescribing policy and practice within ED of Wilkes Regional Medical Center  Increased access to Naloxone and understanding of when and how to use  Pill take-back days  Community awareness, coalition building for community education Reduction in unintentional poisoning deaths, especially those stemming from narcotics prescribed by providers based in Wilkes County

5 Unintentional Poisoning Deaths by County: N.C., Source: N.C. State Center for Health Statistics, Vital Statistics-Deaths, Analysis by Injury Epemiology and Surveillance Unit

6 Unintentional Poisoning Deaths by County: N.C., Source: N.C. State Center for Health Statistics, Vital Statistics-Deaths, Analysis by Injury Epemiology and Surveillance Unit

7 Unintentional Poisoning Deaths by County: N.C., Source: N.C. State Center for Health Statistics, Vital Statistics-Deaths, Analysis by Injury Epemiology and Surveillance Unit

8 Poisonings on the Rise *Source: NC. State Center for Health Statistics; annually generated poisoning report for Project Lazarus. ** Mortality rates calculated from bridged population estimates ( ) and 2010 US Census counts. Mortality rate/100,000 population NC mortality rates, unintentional and undetermined intent poisonings,

9 Problem Acute in Wilkes County Mortality rate/100,000 population Source: NC SCHS, August 2009 Unintentional and undetermined intent poisoning mortality rates Wilkes County, NC

10 NC Cost of Hospitalizations for Unintentional Poisonings  Average cost of inpatient hospitalizations for an opioid poisoning*: $16,970  Number of hospitalizations for unintentional and undetermined intent poisonings**: 5,833  Estimated costs (2008): $98,986,010 Does not include costs for hospitalized substance abuse * Agency for Healthcare Research and Quality ** NC State Center for Health Statistics, data analyzed and prepared by K. Harmon, Injury and Violence Prevention Branch, DPH, 1/19/2011

100 North Carolina counties # Cost Patients with >12 opioid scripts and >=10 ED visits in past 12 months 2,256 ED Visits (average per visit cost $2,610.00) $5,881,160 >12 narcotics16,172 Medicaid Network Patient Case Management

12 Controlled Substances/Overdoses

13 Opioids a Rising NC Problem t *Source: NC State Center for Health Statistics; annually generated poisoning report for Project Lazarus Narcotics causing or contributing to fatal unintentional and undetermined intent poisonings*: N.C. residents,

14 Key Ingredients in Chronic Pain Initiative Establishment (or prior existence) of a community coalition that is able to develop and implement effective strategies to reduce substance use  A sense of urgency among local actors who have influence  Dedicated manager of the coalition with skills in process and content Appropriate strategy for achieving a change in prevailing medical practice re: treatment of chronic pain patients (PCP and ED locations)  Tailored to local conditions  Includes education on the extent of the problem in the community and the role of providers in limiting supply and opportunities for diversion  Includes useful tools that providers can adopt (e.g., Medication Agreements, guidelines for proper script writing)  Explicit recommendations for hospital policies that limit dispensing of narcotics (especially to ED patients)  Take advantage of leverage points in larger environment (e.g., CSRS, Medicaid lock-in)

15 Key Ingredients in Chronic Pain Initiative  Makes effective use of various partners in carrying out strategies including but not limited to:  Public health department – multiple strategies  County Medical Director – to reach physicians and ED  Medical providers – to change their own practice and educate other providers  Pharmacist – to other pharmacies in community  Law enforcement  Schools  Behavioral Health, Prevention and Treatment Programs and Organizations

16 Contents of the Toolkit  General information o Managing chronic pain o Proper prescription writing o Precautions  Tools for managing chronic pain patients o Universal Precaution for Prescribing and Algorithm for assessing and managing pain o Pain Treatment Agreement o Format for progress notes o Medication flowsheet o Personal care plan o Prescriber and Patient education materials o Screening Forms and Brief Intervention o Naloxone Prescribing o Controlled Substance Reporting System (CSRS)

17 Primary Care Tool Kit  Physician toolkit for treating chronic pain patients  Encourage the use of Pain Treatment Agreements with chronic pain patients  Encourage use of Provider Portal  Encourage use of Controlled Substance Reporting System (CSRS)  Encourage the assignment of pharmacy home for chronic pain patients lock-in program

18 Emergency Department Tool Kit  Care management for pain patients visiting ED  ED policy that restricts the dispensing of narcotics  Encourage the Use of the CSRS by ED physicians  Encourage the Use of Provider Portal in the ED  Identify Chronic Pain Patients and Refer for Care Coordination based on ED assessment

19 Care Management Tool Kit  Provide support to ED identification of chronic pain patients- referrals to PCP or specialty services  Provide care management for patients identified by PCP practice as CPI patient; consider pharmacy lock-in program  Ongoing care management for Medicaid patients with narcotic prescriptions above threshold pain patients via TREO data  Educate PCPs and providers in utilization of Chronic Pain Tool Kit

Project Lazarus Results 1. Lower Risk in the Community 2. Similar Benefit to Patients 3. Improved Risk : Benefit 15%  69% 15%  20

21 Can coalitions help reduce Rx drug abuse?  Counties with coalitions had 6.2% lower rate of ED visits for substance abuse than counties with no coalitions (could be due to random chance)  However, counties with a coalition where the health department was the lead agency had a statistically significant 23% lower rate of ED visits (X 2 =2.15, p=0.03) than other counties  In counties with coalitions 1.7% more residents received opioids than in counties without a coalition.  Coalitions may be useful in reducing the harms of Rx drug abuse while improving access to pain medications.  More professional coalitions may have a greater impact on reducing Rx drug harms. Data Sources: NC Health Directors Survey, NC DETECT (2010), CSRS ( )

22

23 Contact  Dr. Mike Lancaster   Fred Wells Brason II  